Next report date
Report period
Q1 2024
EPS estimate
−0.05SEK
Revenue estimate
57.75 MSEK
−388.17 MSEK
238.73 MSEK
1.37 B
Om XBRANE BIOPHARMA AB
Sektor
Bransch
VD
Martin Åmark
Webbplats
Huvudkvarter
Solna
Employees (FY)
93
Grundat
2008
ISIN
SE0007789409
FIGI
BBG00BV3XZL7
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
